Marina Konopleva

Now

Trials, publications and grants since Nov 2024.

• Publication

  Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy.

  Blood, Feb 2026

• Publication

  Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.

  Leukemia, Jan 2026

• Publication

  Blastic plasmacytoid dendritic cell neoplasm (BPDCN): international, multi-center collaboration and global registry program.

  Discover oncology, Dec 2025

• Publication

  The LSC17 score: a prognostic biomarker now validated for real-world clinical application in acute myeloid leukemia.

  Haematologica, Dec 2025

• Publication

  A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias.

  Journal of hematology & oncology, Nov 2025

• Publication

  Menin inhibitor DS-1594b drives differentiation and induces synergistic lethality in combination with venetoclax in acute myeloid leukemia cells with rearranged mixed-lineage leukemia and mutated nucleophosmin-1.

  Haematologica, Nov 2025

Affiliations

• The University of Texas MD Anderson Cancer Center
• Albert Einstein College of Medicine
• Montefiore Einstein Comprehensive Cancer Center
• Montefiore Medical Center

Co-authors

• CDCourtney D DiNardoHow are we linked?
• GTGuilin TangHow are we linked?

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.